🇺🇸 Dasatinib Tablets in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Chylothorax — 2 reports (16.67%)
  2. Drug Ineffective — 2 reports (16.67%)
  3. Bone Marrow Failure — 1 report (8.33%)
  4. Drug Effect Incomplete — 1 report (8.33%)
  5. Drug Intolerance — 1 report (8.33%)
  6. Drug Resistance — 1 report (8.33%)
  7. Escherichia Sepsis — 1 report (8.33%)
  8. Growth Retardation — 1 report (8.33%)
  9. Leukaemia Recurrent — 1 report (8.33%)
  10. Multiple Organ Dysfunction Syndrome — 1 report (8.33%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Dasatinib Tablets approved in United States?

Dasatinib Tablets does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Dasatinib Tablets in United States?

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.